177 related articles for article (PubMed ID: 31453782)
21. Genetic variation in CYP2A6-mediated nicotine metabolism alters smoking behavior.
Tyndale RF; Sellers EM
Ther Drug Monit; 2002 Feb; 24(1):163-71. PubMed ID: 11805739
[TBL] [Abstract][Full Text] [Related]
22. Associations of CYP2A6 genotype with smoking behaviors in southern China.
Liu T; David SP; Tyndale RF; Wang H; Zhou Q; Ding P; He YH; Yu XQ; Chen W; Crump C; Wen XZ; Chen WQ
Addiction; 2011 May; 106(5):985-94. PubMed ID: 21205058
[TBL] [Abstract][Full Text] [Related]
23. Use of a predictive model derived from in vivo endophenotype measurements to demonstrate associations with a complex locus, CYP2A6.
Bloom AJ; Harari O; Martinez M; Madden PA; Martin NG; Montgomery GW; Rice JP; Murphy SE; Bierut LJ; Goate A
Hum Mol Genet; 2012 Jul; 21(13):3050-62. PubMed ID: 22451501
[TBL] [Abstract][Full Text] [Related]
24. Lack of association between smoking and CYP2A6 gene polymorphisms in A Japanese population.
Zhang X; Amemo K; Ameno S; Iwahashi K; Kinoshita H; Kubota T; Mostofa J; Ijiri I
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2001 Oct; 36(5):486-90. PubMed ID: 11725533
[TBL] [Abstract][Full Text] [Related]
25. Genetic influence of dopamine receptor, dopamine transporter, and nicotine metabolism on smoking cessation and nicotine dependence in a Japanese population.
Ohmoto M; Takahashi T; Kubota Y; Kobayashi S; Mitsumoto Y
BMC Genet; 2014 Dec; 15():151. PubMed ID: 25526961
[TBL] [Abstract][Full Text] [Related]
26. Determination of coumarin metabolism in Turkish population.
Cok I; Aygün Kocabaş N; Cholerton S; Karakaya AE; Sardaş S
Hum Exp Toxicol; 2001 Apr; 20(4):179-84. PubMed ID: 11393269
[TBL] [Abstract][Full Text] [Related]
27. Genome-wide association study of a nicotine metabolism biomarker in African American smokers: impact of chromosome 19 genetic influences.
Chenoweth MJ; Ware JJ; Zhu AZX; Cole CB; Cox LS; Nollen N; Ahluwalia JS; Benowitz NL; Schnoll RA; Hawk LW; Cinciripini PM; George TP; Lerman C; Knight J; Tyndale RF;
Addiction; 2018 Mar; 113(3):509-523. PubMed ID: 28921760
[TBL] [Abstract][Full Text] [Related]
28. Determinants of the rate of nicotine metabolism and effects on smoking behavior.
Johnstone E; Benowitz N; Cargill A; Jacob R; Hinks L; Day I; Murphy M; Walton R
Clin Pharmacol Ther; 2006 Oct; 80(4):319-30. PubMed ID: 17015050
[TBL] [Abstract][Full Text] [Related]
29. Drug Metabolizing Enzyme and Transporter Gene Variation, Nicotine Metabolism, Prospective Abstinence, and Cigarette Consumption.
Bergen AW; Michel M; Nishita D; Krasnow R; Javitz HS; Conneely KN; Lessov-Schlaggar CN; Hops H; Zhu AZ; Baurley JW; McClure JB; Hall SM; Baker TB; Conti DV; Benowitz NL; Lerman C; Tyndale RF; Swan GE;
PLoS One; 2015; 10(7):e0126113. PubMed ID: 26132489
[TBL] [Abstract][Full Text] [Related]
30. Predictors of Variation in CYP2A6 mRNA, Protein, and Enzyme Activity in a Human Liver Bank: Influence of Genetic and Nongenetic Factors.
Tanner JA; Prasad B; Claw KG; Stapleton P; Chaudhry A; Schuetz EG; Thummel KE; Tyndale RF
J Pharmacol Exp Ther; 2017 Jan; 360(1):129-139. PubMed ID: 27815364
[TBL] [Abstract][Full Text] [Related]
31. CYP2A6 genetic polymorphisms and correlation with smoking status in Brazilians.
Vasconcelos GM; Struchiner CJ; Suarez-Kurtz G
Pharmacogenomics J; 2005; 5(1):42-8. PubMed ID: 15534625
[TBL] [Abstract][Full Text] [Related]
32. EFFECT OF CYP2A6*4 GENETIC POLYMORPHISMS ON SMOKING BEHAVIORS AND NICOTINE DEPENDENCE IN A GENERAL POPULATION OF JAPANESE MEN.
Ito T; Tsuji M; Mori Y; Kanda H; Hidaka T; Kakamu T; Kumagai T; Hayakawa T; Osaki Y; Fukushima AT
Fukushima J Med Sci; 2015; 61(2):125-30. PubMed ID: 26370685
[TBL] [Abstract][Full Text] [Related]
33. CYP2A6 polymorphisms in Malays, Chinese and Indians.
Nurfadhlina M; Foong K; Teh LK; Tan SC; Mohd Zaki S; Ismail R
Xenobiotica; 2006 Aug; 36(8):684-92. PubMed ID: 16891249
[TBL] [Abstract][Full Text] [Related]
34. Novel CYP2A6 diplotypes identified through next-generation sequencing are associated with in-vitro and in-vivo nicotine metabolism.
Tanner JA; Zhu AZ; Claw KG; Prasad B; Korchina V; Hu J; Doddapaneni H; Muzny DM; Schuetz EG; Lerman C; Thummel KE; Scherer SE; Tyndale RF
Pharmacogenet Genomics; 2018 Jan; 28(1):7-16. PubMed ID: 29232328
[TBL] [Abstract][Full Text] [Related]
35. Genome-Wide Association of the Laboratory-Based Nicotine Metabolite Ratio in Three Ancestries.
Baurley JW; Edlund CK; Pardamean CI; Conti DV; Krasnow R; Javitz HS; Hops H; Swan GE; Benowitz NL; Bergen AW
Nicotine Tob Res; 2016 Sep; 18(9):1837-1844. PubMed ID: 27113016
[TBL] [Abstract][Full Text] [Related]
36. CYP2A6 genotype and the metabolism and disposition kinetics of nicotine.
Benowitz NL; Swan GE; Jacob P; Lessov-Schlaggar CN; Tyndale RF
Clin Pharmacol Ther; 2006 Nov; 80(5):457-67. PubMed ID: 17112802
[TBL] [Abstract][Full Text] [Related]
37. CYP2A6 Effects on Subjective Reactions to Initial Smoking Attempt.
Cannon DS; Mermelstein RJ; Medina TR; Pugach O; Hedeker D; Weiss RB
Nicotine Tob Res; 2016 May; 18(5):637-41. PubMed ID: 26541911
[TBL] [Abstract][Full Text] [Related]
38. [Association between genotype and allele frequencies of CYP2A6*12 and rs16969968 in CHRNA5 variants with smoking and body mass index in young subjects from Northeast Mexico].
Borrego-Soto G; Costilla-Esquivel A; Padilla-Rivas GR; Cázares-Samaniego PJ; Posadas-Valay R; Velasco-Castañón JG; Mercado-Longoria R; Ortiz-López R; Rojas-Martínez A
Rev Med Chil; 2015 Nov; 143(11):1377-85. PubMed ID: 26757861
[TBL] [Abstract][Full Text] [Related]
39. Association between CYP2A6 genetic polymorphisms and lung cancer: a meta-analysis of case-control studies.
Liu T; Xie CB; Ma WJ; Chen WQ
Environ Mol Mutagen; 2013 Mar; 54(2):133-40. PubMed ID: 23203414
[TBL] [Abstract][Full Text] [Related]
40. Genotyping of human cytochrome P450 2A6 (CYP2A6), a nicotine C-oxidase.
Oscarson M; Gullstén H; Rautio A; Bernal ML; Sinues B; Dahl ML; Stengård JH; Pelkonen O; Raunio H; Ingelman-Sundberg M
FEBS Lett; 1998 Nov; 438(3):201-5. PubMed ID: 9827545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
